Thoracic Neoplasms

Atezolizumab Plus Induction Chemotherapy Plus CT-radiotherapy. (APOLO)

Study of Tarlatamab as Maintenance Treatment After Chemo-radiotherapy for Limited Stage SCLC Patients

Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease

Small/Middle Tier Cities and County Lung Cancer Quality Improvement Project (QIP) Study

Osimertinib With Chemotherapy as First-line Therapy for EGFR Mutation-positive NSCLC

Real World Registry for Use of the Ion Endoluminal System

Local Radiofrequency Ablation Plus External Beam Radiation for the Treatment of Painful Thoracic and Lumbar Spine Tumors

Post-operative Medium Chain Triglyceride Diet May Reduce Hospital Stay Following Lung Resection

A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)

Erector Spinae Block for Thoracic Surgery

Expanded Access Program of Taletrectinib in Patients With Advanced or Metastatic ROS1-Positive NSCLC

Clinical Study of Thiopegfilgrastim for Preventing Bone Marrow Suppression in Thoracic Tumor Chemoradiotherapy

Effectiveness of an Educational Intervention Aimed at Increasing the Emotional Competencies of Patients Under Surveillance After Antineoplastic Treatment of Oesogastric or Bronchopulmonary Cancer

Post-line Treatment With Teniposide for c-Myc-driven Extensive-stage Small Cell Lung Cancer

PALACE: Cemiplimab Trial According to ctDNA Levels

Improving Cancer On-treatment Symptom Management

SPSIPB vs SAPB for Thoracoscopic Surgery

Pain Control After VATS Anatomical Pulmonary Resections

Studying a New Piece of Equipment That Can Help Plan Radiation Therapy of the Spine

Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors